RESEARCHER PROFILE

Shweta Chaudhary

← Back to International Centre for Genetic Engineering and Biotechnology

S

International Centre for Genetic Engineering and Biotechnology

Tuberculosis Research and EpidemiologyImmune responses and vaccinationsDementia and Cognitive Impairment ResearchAsthma and respiratory diseasesInfectious Diseases and Tuberculosis

Shweta Chaudhary works in Tuberculosis Research and Epidemiology, Immune responses and vaccinations, Dementia and Cognitive Impairment Research, Asthma and respiratory diseases, Infectious Diseases and Tuberculosis. Recorded institutional associations include International Centre for Genetic Engineering and Biotechnology, International Centre for Genetic Engineering and Biotechnology, International Centre for Genetic Engineering and Biotechnology.

18Publications
89Citations
4H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. NCoR1 controls immune tolerance in conventional dendritic cells by fine-tuning glycolysis and fatty acid oxidation

    2022 · 58 citations
  2. Dysregulated cysteine metabolism leads to worsened liver pathology in diabetes-tuberculosis comorbid condition

    2024 · 12 citations
  3. Role of Trace Elements Alzheimer’s Disease

    2014 · 7 citations
  4. Rv0495c regulates redox homeostasis in Mycobacterium tuberculosis

    2024 · 4 citations
  5. Single-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses

    2024 · 2 citations
  6. Nuclear Magnetic Resonance Spectroscopic Studies of Human Immunoglobulin ‘G’ in Alzheimer’s Disease

    2014 · 1 citations
  7. Urine metabolome of tuberculosis patients receiving intensive phase of treatment show diurnal variations

    2021 · 1 citations
  8. Dysregulated cysteine metabolism leads to worsened liver pathology in diabetes-tuberculosis comorbid mice

    2022 · 1 citations
  9. Gut microbiota dysbiosis observed in tuberculosis patients resolves partially with anti-tuberculosis therapy

    2023 · 1 citations
  10. Lung Mycobacterium tuberculosis infection perturbs metabolic pathways in non-pulmonary tissues

    2024 · 1 citations
  11. Single-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses

    2025 · 1 citations
  12. Role of Complements and Immunoglobulins in Alzheimer’s Disease

    2014 · 0 citations
  13. Proteomics analysis in urinary bladder cancer patients identifies urinary SOD2 as a predictive marker of recurrence

    2021 · 0 citations
  14. Hypothetical gene Rv0495c regulates redox homeostasis in Mycobacterium tuberculosis

    2023 · 0 citations
  15. Diabetes mellitus and tuberculosis comorbidity induce unique microbial gut dysbiosis and associated metabolome

    2025 · 0 citations
  16. Macrophages of diabetes and tuberculosis co-morbid conditions show perturbed differentiation and metabolic signatures

    2025 · 0 citations
  17. Single-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses

    2025 · 0 citations
  18. Host immunosenescence compromises Mycobacterium tuberculosis clearance

    2026 · 0 citations

← Return to the university profile